Heat shock protein 70 levels in children with nephrotic syndrome

Bağdagül Aksu1, Zeynep Nagehan Yürük Yıldırım2, Asuman Gedikbaşı1

  • 1Department of Pediatric Basic Sciences, Institute of Child Health, İstanbul University, İstanbul, Türkiye.

PubMed

Insights

Urine heat shock protein 70 (uHSP70) levels are elevated in children with steroid-sensitive nephrotic syndrome (SSNS) before treatment and decrease with prednisolone therapy, indicating reduced renal stress. uHSP70 may serve as a biomarker for monitoring treatment response.

Area of Science:

  • Pediatric Nephrology
  • Biomarker Discovery
  • Glomerular Diseases

Background:

  • Idiopathic nephrotic syndrome (NS) is a common glomerular disease in children.
  • Heat shock protein 70 (HSP70) responds to cellular stress, including infections and oxidative stress.
  • Investigating HSP70 in steroid-sensitive nephrotic syndrome (SSNS) can offer insights into disease mechanisms and treatment response.

Purpose of the Study:

  • To evaluate serum and urine HSP70 levels in children with SSNS.
  • To assess changes in HSP70 levels during prednisolone treatment.
  • To determine if HSP70 levels can differentiate between frequently and infrequently relapsing SSNS.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure serum and urine HSP70 levels.
  • Samples were collected from 36 SSNS patients and 35 healthy children at four time points: before treatment and on days 15, 30, and 90.
  • HSP70 levels were analyzed in relation to treatment status and relapse frequency.

Main Results:

  • Pre-treatment urine HSP70 (uHSP70) and uHSP70/creatinine ratios were significantly higher in SSNS patients compared to controls (p<0.0001).
  • Serum HSP70 (sHSP70) levels were lower in SSNS patients before treatment (p=0.002).
  • uHSP70 levels significantly decreased during prednisolone treatment (p<0.0001), while no significant differences in HSP70 levels were observed between frequent and infrequent relapsers.

Conclusions:

  • Elevated uHSP70 in SSNS patients before treatment suggests renal stress and damage.
  • Decreasing uHSP70 levels with prednisolone therapy indicate reduced renal stress and effective treatment.
  • uHSP70 shows potential as a biomarker for monitoring renal damage and treatment response in SSNS, but does not differentiate relapse frequency.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...